Education, intellectually stimulating work and an active lifestyle help preserve cognitive abilities in adults over 65 and ...

About Orchestra BioMed Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device ...

As GLP-1-based therapies reshape weight management, brands are looking beyond appetite control to nutrition quality, protein ...

This narrative review examines how psychobiotics may influence anxiety, depression, bipolar disorder, and schizophrenia ...

Thermal drift, stress, electromagnetic coupling, and verification gaps are turning optical integration into a full-system co-design problem rather than a plug-in bandwidth upgrade.

With the increased popularity of functional beverages, formulators utilize masking ingredients to balance off-notes.

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, ...

CERN quantum sensing dark matter researchers launched a two-week institute on August 31 to build a roadmap for detecting dark ...

An in vivo small-molecule drug screen in developing zebrafish larvae identifies dozens of unique chemical modulators capable of reducing atherogenic apolipoprotein B levels.

A research team from Zhejiang University, China has achieved a major breakthrough in thin-film lithium niobate integrated photonics, developing a mode/wavelength hybrid multiplexing optical ...

LPDDR6 is designed for the next generation of on-device artificial intelligence, and a Chinese memory maker says it has ...

Marfan syndrome is an autosomal dominant connective tissue disorder involving the cardiovascular, ocular, and musculoskeletal systems. The primary therapeutic goal is to slow the ...